| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Canadian Federation of Biological Societies is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
More than 65 academic medical centers use ARUP as their primary reference laboratory and ARUP also provides all laboratory services, including phlebotomy and support services, for the 490-bed University of Utah Hospitals and Clinics. ARUP's 1,700
LUMEDX is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Oakland, CA. To find more information about LUMEDX, please visit www.lumedx.com
Definitive Healthcare is the leading provider of data and intelligence on hospitals, physicians and other healthcare providers. Definitive Healthcare`s data provides clients with the analytics and insight needed to effectively segment and research the healthcare provider market.